According to the results of network pharmacology analysis, genes related to amino acid metabolism play a key role in mediating the anti-PD activity of BCT, and regulation of amino acid metabolism may be one of the main mechanisms of anti-PD effect of BCT combination. This evidence concerns the gene PCYT1B and Parkinson disease.